Lv2
170 积分 2025-03-16 加入
Effect of Different 131I Dose Strategies for Treatment of Hyperthyroidism on Graves’ Ophthalmopathy
6小时前
已完结
Response to Comment on: “Alpha-1 antagonist treatment for eyelid retraction in patients with thyroid eye disease – a prospective pilot study”
8小时前
待确认
Peri‐levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease‐associated upper eyelid retraction
27天前
已完结
Transconjunctival Triamcinolone Injection for Upper Lid Retraction in Thyroid Eye Disease—A New Injection Method
27天前
已完结
[Chinese guideline on the diagnosis and treatment of thyroid-associated ophthalmopathy (2022)]
1个月前
已完结
Traitement de la rétraction palpébrale supérieure associée à l’ophtalmopathie dysthyroïdienne en phase active inflammatoire avec l’injection de toxine botulique A
1个月前
已完结
Botulinum Toxin Treatment in Thyroid Eye Disease: A Systematic Review and Meta-analysis
1个月前
已完结
Effects of Teprotumumab on Eyelid Retraction in Thyroid Eye Disease
1个月前
已完结
Synergistic Therapy for Graves’ Ophthalmopathy-Associated Eyelid Retraction: Steroid, 5-FU, and Botulinum Neurotoxin a Combination
1个月前
已完结
Triamcinolone acetonide and botulinum toxin A for upper eyelid retraction in thyroid-associated ophthalmopathy
1个月前
已完结
皖公网安备34019202002308
